Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional)
Funder: National Institutes of Health
AGENCY
National Institutes of Health
PROGRAM
Discretionary
AMOUNT
Up to $2.5M
CLOSES
Oct 10, 2028
Description
This Notice of Funding Opportunity (NOFO) supports the translation of genome editing and other biologic therapies for Alzheimer's Disease-Related Dementias (ADRD). The program spans the full translational pipeline, from therapeutic lead optimization and drug product development through IND-enabling studies and early clinical evaluation. Supported activities may include optimization of editing constructs and delivery systems; assessment of bioactivity, target engagement, durability, pharmacokinetics, and bioavailability; demonstration of in vivo efficacy; execution of safety pharmacology and toxicology studies; and development of scalable manufacturing processes, formulation strategies, and quality attributes aligned with regulatory expectations.
ADRD include Frontotemporal Dementia (FTD); Lewy Body Dementias (LBD), including Dementia with Lewy Bodies (DLB) and Parkinson's Disease Dementia (PDD); Vascular Contributions to Cognitive Impairment and Dementia (VCID); and Multiple Etiology Dementias (MED).
Eligibility
State governments; Native American tribal governments (Federally recognized); Private institutions of higher education; For profit organizations other than small businesses; City or township governments; Special district governments; Native American tribal organizations (other than Federally recognized tribal governments); Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; Independent school districts; Public housing authorities/Indian housing authorities; Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; Small businesses; Others (see text field entitled "Additional Information on Eligibility" for clarification); Public and State controlled institutions of higher education; County governments
Contact
Additional details
- Department
- HHS-Nih11
- Funding instrument
- Cooperative Agreement
- Cost sharing required
- No
- Archived
- Dec 9, 2028
Opportunity number: RFA-NS-28-012
Quote this number when you contact the agency or apply.